Presented » Pr Newswire - New Mobile Phones, Laptops, Gadgets Technology News

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog at American Diabetes Association's 85th Scientific Sessions

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes and overweight, non-obese individuals Preclinical data for BGM1812 supports...

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association's 85th Scientific Sessions

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly treatment in patients with type 2 diabetes mellitus (T2DM), with significant HbA1c reductions...

Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025

HONG KONG, June 16, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") presented the subgroup analysis data from the Phase III COMPASSION-16 trial, evaluating cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody, in the...

G-DRAGON 2025 WORLD TOUR [Übermensch] IN MACAU, QQ MUSIC Attracts Over 7 Million Simultaneous Users

SHENZHEN, China, June 10, 2025 /PRNewswire/ -- Promoted by AEG Presents, TME live and Chessman, G-DRAGON 2025 WORLD TOUR [Übermensch] IN MACAU, presented by Galaxy Macau™, is sponsored by The Hong Kong and Shanghai Banking Corporation Limited...

Top Michelin Chefs Steer a 10-Star Epicurean Adventure Through East Asia at the Third Edition of MGM x RR1HK Culinary Masters Macau

Exemplifying Gastronomic Excellence in a Harmonious Blend to Celebrate Macau as the Creative City of Gastronomy and the Culture City of East Asia MACAU, June 10, 2025 /PRNewswire/ -- MGM x RR1HK Culinary Masters Macau 2025, the highly anticipated...

Wingderm® Strengthens Presence in Asia at IMCAS Asia 2025

BEIJING, June 10, 2025 /PRNewswire/ -- From June 6 to 8, 2025, IMCAS Asia was successfully held in Bangkok, Thailand. As one of the world's leading medical aesthetic events, IMCAS Asia brought together the latest developments and trends in the Asian...

Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach

Phase IIa study results of Rentosertib were published simultaneously in Nature Medicine(IF = 58.7) and presented at the American Thoracic Society (ATS) 2025. Encouraging clinical data showed that patients receiving 60 mg QD Rentosertib experienced...

Alphamab Oncology Presented Multiple Clinical Data of Anti-HER2 Biparatopic ADC JSKN003 at the 2025 ASCO Annual Meeting

SUZHOU, China, June 3, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that multiple clinical data updates for anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 were presented as posters at the 2025 Annual Meeting of...

Mega Matrix Inc. Presented FlexTV Weekly Highlights from May 19 to 23, 2025, Featuring Desire Maze, Ethical Dilemmas and Breakthrough Manual

SINGAPORE, May 28, 2025 /PRNewswire/ -- Mega Matrix Inc. (NYSE American: MPU) launched seven English mini-series on its short drama platform FlexTV between May 19 and May 23, 2025, each illuminating life's myriad vicissitudes. Through tales of...

Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTnm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting

TAIPEI, May 23, 2025 /PRNewswire/ -- GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-38, an novel epigenetic immune activator for cancer immunotherapy. GNTbm-38 was presented as posters at the 2025 American Association of...